A rationale for setting target plasma lipid levels to reverse atherosclerosis.
Parker
T S
TS
Rogosin Institute, New York, New York.
Saal
S D
SD
Gordon
B R
BR
Tyberg
T I
TI
Levine
D M
DM
Rubin
A L
AL
D000818:Animals; D001161:Arteriosclerosis / Q000097:blood* / Q000628:therapy; D002784:Cholesterol / Q000097:blood; D008076:Cholesterol, HDL / Q000097:blood; D003131:Combined Modality Therapy; D006801:Humans; D008055:Lipids / Q000097:blood*; D008077:Lipoproteins, LDL / Q000097:blood; D010956:Plasmapheresis
D008076:Cholesterol, HDL; D008055:Lipids; D008077:Lipoproteins, LDL; D002784:Cholesterol